$7.93
Price
$1.8B
Market Cap
11.7
P/E Ratio
7.5
Forward P/E
$0.68
EPS (TTM)
—
Dividend Yield
$55.9B
Cash
$80M
Total Debt
232M
Shares Out
$7.21
$22.37
52-Week Range
Institutional Ownership of ADMA BIOLOGICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Fundsmith|Terry Smith
|
1.6M | $15M | $15.69 | +2.55% |
Trading Activity for ADMA BIOLOGICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -21.5% | 1.6M | $15M | $16.29 | |
| 2025-Q4 | |||||
| BUY | NEW | 2.1M | $38M | $15.69 | |
| 2025-Q3 | |||||
| SELL | EXIT | — | — | $17.20 | |
| 2025-Q2 | |||||
| BUY | NEW | 30.4K | $553803 | $20.23 | |
Insider Trading for ADMA BIOLOGICS INC
6 Months Insider Sentiment
Buy $0
Sell $416K
0
Buys
2
Sells
-416K
Net
0
Grants
Largest
$297K
Grossman
$119K
Grossman
$81K
Grossman
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | Adam S Grossman | President and CEO | EXERCISE | 15.0K | $5.40 | $81K |
| Dec 15, 2025 | Adam S Grossman | President and CEO | SELL | 6.0K | $19.79 | $119K |
| Dec 15, 2025 | Adam S Grossman | President and CEO | SELL | 15.0K | $19.79 | $297K |